Lipids & metabolic liver disease

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

Diabetes Obes MetabPublished Mendelian randomization and mediation analysis

Authors' conclusion

The MAFLD panels have good diagnostic accuracy, and the causal link between PEG10 and MAFLD was mediated by the percentage of CD11c + CD62L- monocytes.

Study context

Population
Patients with biopsy-proven MAFLD (published transcriptome data); cohort of 778,614 Europeans for Mendelian randomizationEuropeans, MR cohort
Participants
778,614 patients
Outcome
Identification of MAFLD (AUROC)
Methodological detailstranscriptome analysis, least absolute shrinkage and selector operation (LASSO) regression, ROC curve analysis, inverse variance-weighted analysis
  • Transcriptome analysis
  • LASSO regression
  • ROC curve analysis
  • Inverse variance-weighted analysis

Main finding

As reported in the abstract

GroupArea under the receiver operating characteristic (AUROC)
IGFBP20.807
PEG100.772
P4HA10.791

Area under the receiver operating characteristic (AUROC)

IGFBP20.807
PEG100.772
P4HA10.791
Three-gene model AUROC, development data set
0.959
Three-gene model AUROC, validation data set
0.800

Further findings

OutcomeORP value
Causal association of PEG10 with MAFLD risk (Mendelian randomization, inverse variance-weighted)Increased MAFLD risk1.106P = 0.032
Causal association of PEG10 with MAFLD risk (Mendelian randomization, inverse variance-weighted) — Share of risk mediated by % CD11c + CD62L- monocytes
about 30%

Validation of the model with serum ELISA data from MAFLD patients and controls

AUROC
0.819 (0.736-0.902) (95% CI)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis. Diabetes Obes Metab. Published 4 September 2024. doi:10.1111/dom.15925

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.